东北制药:控股股东一致行动人增持0.106%
Core Viewpoint - Northeast Pharmaceutical (000597) announced that its controlling shareholder's concerted action party, Jiangxi Fangda Steel Group Co., Ltd., will increase its shareholding in the company by 1.5175 million shares from April 9 to April 15, 2025, representing 0.106% of the total share capital [1] Group 1 - After this increase, the controlling shareholder and its concerted action parties will hold a total of 786 million shares, accounting for 55.00% of the company's total share capital [1] - The share increase is supported by a special loan for stock repurchase and increase, amounting to RMB 108 million, with a loan term of 36 months and an interest rate of 2.25% [1]